With such a hefty price tag attached to the da Vinci robot, many hospitals we work with wonder: How many of the 450,000 robotics procedures performed in 2012 alone were worth the additional cost?
High cost, little gain in robotic hysterectomy case
When compared to open surgery, minimally invasive techniques require smaller incisions and lead to shorter hospital stays, less postoperative pain, and faster recovery for patients.
Recent research published in the Daily Briefing uses the example of benign hysterectomies to assess the impact of the robot on patient outcomes compared to laparoscopy—both minimally invasive techniques, but one vastly more expensive than the other.
Unfortunately, the study found that despite higher costs, the robot did not confer significant clinical advantages in the cases considered.
The study’s conclusions look bad for the robot. However, there are exceptions to this discouraging outlook for robotic hysterectomies. Some procedures do improve patient outcomes when switching from open surgery to the robot, and certain patients with comorbidities or especially challenging anatomies may benefit more from robotic procedures.
Why continue to invest?
Despite the negative press on the effectiveness of using the robot, we see hospitals continuing to market this technology for three reasons:
- Physicians are coming out of residency trained in robotics and many require it as a condition for practicing at a hospital.
- Hospitals feel that if they do not have the robot, they will be left behind.
- For procedures that are currently done openly, it can make a big difference. Providers should prioritize these procedures over procedures already done laparoscopically.
Impetus for investing may soon change
As hospitals become more focused on finding cost-effective patient care alternatives, the robot may become a less attractive investment. Intuitive Surgical is still pushing the robot into new areas, such as general surgery, but these efforts may be met with scrutiny.
Many general surgeons already perform procedures laparoscopically and are less interested in switching over if there is not a clear benefit to their patients.
Many members have recently expressed skepticism toward investing, and administrators are not as willing to bend to physician demands as they have been in the past. However, da Vinci sales are growing, albeit at a slower rate, indicating that hospitals haven’t yet made the shift away from robotics.
Where Does Your Facility Stand on Robotics?
What are your opinions on robotics investments? Please tell us your thoughts below in the comments box, once you're logged in. Forgot your password? Reset it here. We’re interested in your experiences.